HEL cells harbor multiple copies of JAK2-V617F as the underlying MPN-driver mutation and a loss of p53, a genetic constellation that is typical and critical for progression and dismal prognosis of blast-phase MPN [7, 8, 18]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.